A comprehensive review published in Current Pharmaceutical Design summarizing over two decades of BPC-157 preclinical research, covering musculoskeletal, gastrointestinal, and systemic healing outcomes, reinforces its consistent repair activity across tissue types
50100 mg once daily subcutaneously, starting low and titrating up to tolerance (flushing or GI upset) across an 812 week course
Without proper hydration and essential nutrients, you risk prolonged fatigue, weakened immunity, and longer recovery times from illness or physical exertion
What makes plantar fasciitis particularly frustrating is its tendency to become chronic
Subcutaneous bioavailability may land somewhere around 30 to 80 percent depending on the site, and local injection could in theory help in superficial, low-blood-flow tissues like tendons
The Science